Creative Planning’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
196,885
+21,136
+12% +$91.4K ﹤0.01% 2547
2026
Q1
$680K Buy
175,749
+5,130
+3% +$21K ﹤0.01% 2780
2025
Q4
$713K Sell
170,619
-1,937
-1% -$7.49K ﹤0.01% 2553
2025
Q3
$568K Buy
172,556
+78,265
+83% +$221K ﹤0.01% 2600
2025
Q2
$134K Buy
94,291
+52,901
+128% +$75.2K ﹤0.01% 3368
2025
Q1
$61.7K Buy
41,390
+16,213
+64% +$25.5K ﹤0.01% 3318
2024
Q4
$28.2K Sell
25,177
-3,807
-13% -$3.25K ﹤0.01% 3306
2024
Q3
$27.5K Sell
28,984
-7,932
-21% -$10K ﹤0.01% 3137
2024
Q2
$58.3K Buy
36,916
+3,882
+12% +$5.64K ﹤0.01% 2914
2024
Q1
$47.9K Buy
33,034
+8,312
+34% +$11.9K ﹤0.01% 2787
2023
Q4
$33.1K Sell
24,722
-204,920
-89% -$241K ﹤0.01% 2672
2023
Q3
$326K Buy
229,642
+2,136
+0.9% +$3.03K ﹤0.01% 1864
2023
Q2
$262K Buy
227,506
+2,799
+1% +$3.3K ﹤0.01% 2014
2023
Q1
$238K Sell
224,707
-1,200
-0.5% -$1.73K ﹤0.01% 1992
2022
Q4
$343K Buy
225,907
+11,457
+5% +$19.7K ﹤0.01% 1638
2022
Q3
$455K Hold
214,450
﹤0.01% 1392
2022
Q2
$287K Buy
214,450
+170,000
+382% +$252K ﹤0.01% 1643
2022
Q1
$94K Hold
44,450
﹤0.01% 1996
2021
Q4
$165K Buy
44,450
+29,945
+206% +$129K ﹤0.01% 1903
2021
Q3
$72K Sell
14,505
-73,434
-84% -$423K ﹤0.01% 1976
2021
Q2
$573K Sell
87,939
-102,157
-54% -$714K ﹤0.01% 1203
2021
Q1
$1.31M Buy
190,096
+28,707
+18% +$243K ﹤0.01% 904
2020
Q4
$1.65M Buy
161,389
+15,000
+10% +$97.2K ﹤0.01% 742
2020
Q3
$512K Sell
146,389
-1,100
-0.7% -$5.22K ﹤0.01% 1123
2020
Q2
$736K Sell
147,489
-15,663
-10% -$53.3K ﹤0.01% 865
2020
Q1
$555K Buy
163,152
+6,523
+4% +$28.1K ﹤0.01% 890
2019
Q4
$858K Buy
156,629
+12,200
+8% +$68.7K ﹤0.01% 860
2019
Q3
$826K Sell
144,429
-1,364
-0.9% -$9.27K ﹤0.01% 841
2019
Q2
$1.12M Buy
145,793
+66,500
+84% +$358K ﹤0.01% 722
2019
Q1
$417K Hold
79,293
﹤0.01% 1134
2018
Q4
$519K Buy
79,293
+1,000
+1% +$11.2K ﹤0.01% 951
2018
Q3
$1.35M Buy
78,293
+5,437
+7% +$80.9K 0.01% 628
2018
Q2
$1.02M Sell
72,856
-350
-0.5% -$5.91K ﹤0.01% 739
2018
Q1
$1.12M Buy
73,206
+22,913
+46% +$328K ﹤0.01% 674
2017
Q4
$579K Sell
50,293
-303
-0.6% -$4.51K ﹤0.01% 993
2017
Q3
$962K Buy
50,596
+25,188
+99% +$518K ﹤0.01% 731
2017
Q2
$612K Buy
25,408
+3,100
+14% +$68K ﹤0.01% 921
2017
Q1
$442K Buy
22,308
+8,423
+61% +$188K ﹤0.01% 1050
2016
Q4
$334K Buy
13,885
+10,895
+364% +$303K ﹤0.01% 1141
2016
Q3
$83K Sell
2,990
-4,048
-58% -$107K ﹤0.01% 1967
2016
Q2
$172K Buy
7,038
+2,472
+54% +$70.1K ﹤0.01% 1328
2016
Q1
$153K Sell
4,566
-2,018
-31% -$63.5K ﹤0.01% 1362
2015
Q4
$197K Buy
6,584
+3,153
+92% +$106K ﹤0.01% 1204
2015
Q3
$108K Sell
3,431
-34,476
-91% -$1.68M ﹤0.01% 1552
2015
Q2
$1.83M Buy
37,907
+35,814
+1,711% +$1.51M 0.02% 312
2015
Q1
$91K Hold
2,093
﹤0.01% 1630
2014
Q4
$55K Sell
2,093
-2,092
-50% -$45.9K ﹤0.01% 1950
2014
Q3
$74K Hold
4,185
﹤0.01% 1663
2014
Q2
$101K Buy
4,185
+2,092
+100% +$42.4K ﹤0.01% 1421
2014
Q1
$53K Hold
2,093
﹤0.01% 1767
2013
Q4
$48K Buy
2,093
+1,988
+1,893% +$40.2K ﹤0.01% 1633
2013
Q3
$2K Buy
+105
New +$2.42K ﹤0.01% 2995

Other funds holding PGEN

Creative Planning's PGEN Position: Q2 2026 in Review

Creative Planning increased its Precigen (PGEN) stake by 12% in Q2 2026, buying an estimated $91.4K and bringing the position to 196,885 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

Creative Planning first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. The position peaked at $1.83M in Q2 2015. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Creative Planning held 196,885 shares of Precigen worth $1.12M as of Q2 2026.
  • Creative Planning bought 21,136 Precigen shares in Q2 2026, an estimated $91.4K.
  • Precigen made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2547 holding.
  • Creative Planning first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
  • Creative Planning's Precigen position peaked at $1.83M in Q2 2015.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.